Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 260

1.

Elevated maspin expression is associated with better overall survival in esophageal squamous cell carcinoma (ESCC).

Wang Y, Sheng S, Zhang J, Dzinic S, Li S, Fang F, Wu N, Zheng Q, Yang Y.

PLoS One. 2013 May 22;8(5):e63581. doi: 10.1371/journal.pone.0063581. Print 2013. Erratum in: PLoS One. 2014;9(8):e104715.

2.

Abnormal Localization and Tumor Suppressor Function of Epithelial Tissue-Specific Transcription Factor ESE3 in Esophageal Squamous Cell Carcinoma.

Wang L, Xing J, Cheng R, Shao Y, Li P, Zhu S, Zhang S.

PLoS One. 2015 May 7;10(5):e0126319. doi: 10.1371/journal.pone.0126319. eCollection 2015.

3.

Loss of Protein Tyrosine Phosphatase Receptor J Expression Predicts an Aggressive Clinical Course in Patients with Esophageal Squamous Cell Carcinoma.

Qiao D, Li M, Pu J, Wang W, Zhu W, Liu H.

Pathol Oncol Res. 2016 Jul;22(3):541-7. doi: 10.1007/s12253-015-0036-3. Epub 2015 Dec 23.

PMID:
26694178
4.

RACK1 predicts poor prognosis and regulates progression of esophageal squamous cell carcinoma through its epithelial-mesenchymal transition.

Wang N, Liu F, Cao F, Jia Y, Wang J, Ma W, Tan B, Wang K, Song Q, Cheng Y.

Cancer Biol Ther. 2015;16(4):528-40. doi: 10.1080/15384047.2015.1016687. Epub 2015 Feb 26.

5.

Expression and role of anion exchanger 1 in esophageal squamous cell carcinoma.

Shiozaki A, Kudou M, Ichikawa D, Shimizu H, Arita T, Kosuga T, Konishi H, Komatsu S, Fujiwara H, Okamoto K, Kishimoto M, Marunaka Y, Otsuji E.

Oncotarget. 2017 Mar 14;8(11):17921-17935. doi: 10.18632/oncotarget.14900.

6.

Overexpression of zinc finger E-box binding homeobox factor 1 promotes tumor invasiveness and confers unfavorable prognosis in esophageal squamous cell carcinoma.

Yang X, Wang Q, Dai W, Zhang J, Chen X.

Tumour Biol. 2014 Dec;35(12):11977-84. doi: 10.1007/s13277-014-2494-8. Epub 2014 Aug 21.

PMID:
25142232
7.

Identification of an invasion and tumor-suppressing gene, Endoglin (ENG), silenced by both epigenetic inactivation and allelic loss in esophageal squamous cell carcinoma.

Wong VC, Chan PL, Bernabeu C, Law S, Wang LD, Li JL, Tsao SW, Srivastava G, Lung ML.

Int J Cancer. 2008 Dec 15;123(12):2816-23. doi: 10.1002/ijc.23882.

8.

[Expression and significance of FoxM1 in esophageal squamous cell carcinoma cells in vitro and in vivo].

Gai L, Mao GX, Liu J, Huang H, Wang X, Yao NH.

Zhonghua Zhong Liu Za Zhi. 2016 Mar 23;38(3):179-84. doi: 10.3760/cma.j.issn.0253-3766.2016.03.004. Chinese.

PMID:
26988822
9.

Epigenetic inactivation of secreted frizzled-related protein 2 in esophageal squamous cell carcinoma.

Hao XW, Zhu ST, He YL, Li P, Wang YJ, Zhang ST.

World J Gastroenterol. 2012 Feb 14;18(6):532-40. doi: 10.3748/wjg.v18.i6.532.

10.

MicroRNA-340 Inhibits Esophageal Cancer Cell Growth and Invasion by Targeting Phosphoserine Aminotransferase 1.

Yan S, Jiang H, Fang S, Yin F, Wang Z, Jia Y, Sun X, Wu S, Jiang T, Mao A.

Cell Physiol Biochem. 2015;37(1):375-86. doi: 10.1159/000430361. Epub 2015 Aug 27.

11.

Epigenetic silencing of HIC1 promotes epithelial-mesenchymal transition and drives progression in esophageal squamous cell carcinoma.

Li P, Liu X, Dong ZM, Ling ZQ.

Oncotarget. 2015 Nov 10;6(35):38151-65. doi: 10.18632/oncotarget.5832.

12.

Expression and clinical significance of REPS2 in human esophageal squamous cell carcinoma.

Zhang H, Duan CJ, Zhang H, Cheng YD, Zhang CF.

Asian Pac J Cancer Prev. 2013;14(5):2851-7.

13.

MiRNA-205 modulates cellular invasion and migration via regulating zinc finger E-box binding homeobox 2 expression in esophageal squamous cell carcinoma cells.

Matsushima K, Isomoto H, Yamaguchi N, Inoue N, Machida H, Nakayama T, Hayashi T, Kunizaki M, Hidaka S, Nagayasu T, Nakashima M, Ujifuku K, Mitsutake N, Ohtsuru A, Yamashita S, Korpal M, Kang Y, Gregory PA, Goodall GJ, Kohno S, Nakao K.

J Transl Med. 2011 Mar 22;9:30. doi: 10.1186/1479-5876-9-30.

14.

miR-143 inhibits tumor progression by targeting FAM83F in esophageal squamous cell carcinoma.

Mao Y, Liu J, Zhang D, Li B.

Tumour Biol. 2016 Jul;37(7):9009-22. doi: 10.1007/s13277-015-4760-9. Epub 2016 Jan 13. Erratum in: Tumour Biol. 2016 Oct 24;:.

PMID:
26758433
15.

Upregulation of the long non-coding RNA BANCR correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma.

Liu Z, Yang T, Xu Z, Cao X.

Biomed Pharmacother. 2016 Aug;82:406-12. doi: 10.1016/j.biopha.2016.05.014. Epub 2016 May 31.

PMID:
27470379
16.

The molecular role of Fra-1 and its prognostic significance in human esophageal squamous cell carcinoma.

Usui A, Hoshino I, Akutsu Y, Sakata H, Nishimori T, Murakami K, Kano M, Shuto K, Matsubara H.

Cancer. 2012 Jul 1;118(13):3387-96. doi: 10.1002/cncr.26652. Epub 2011 Oct 25.

17.

Reduced expression of DENND2D through promoter hypermethylation is an adverse prognostic factor in squamous cell carcinoma of the esophagus.

Hibino S, Kanda M, Oya H, Takami H, Shimizu D, Nomoto S, Hishida M, Niwa Y, Koike M, Yamada S, Nishikawa Y, Asai M, Nakayama G, Fujii T, Sugimoto H, Fujiwara M, Kodera Y.

Oncol Rep. 2014 Feb;31(2):693-700. doi: 10.3892/or.2013.2901. Epub 2013 Dec 5.

PMID:
24317529
18.

Under-expression of annexin A2 is associated with Kazakh's esophageal squamous cell carcinoma.

Li X, Zheng S, Liu Q, Liu T, Liang M, Gao X, Lu M, Sheyhidin I, Lu X.

Mol Carcinog. 2015 Sep;54(9):779-88. doi: 10.1002/mc.22145. Epub 2014 Mar 26.

PMID:
24668792
19.

Long noncoding RNA, tissue differentiation-inducing nonprotein coding RNA is upregulated and promotes development of esophageal squamous cell carcinoma.

Xu Y, Qiu M, Chen Y, Wang J, Xia W, Mao Q, Yang L, Li M, Jiang F, Xu L, Yin R.

Dis Esophagus. 2016 Nov;29(8):950-958. doi: 10.1111/dote.12436. Epub 2016 Feb 2.

PMID:
26833746
20.

Effect and mechanism of RUNX3 gene on biological characteristics of human esophageal squamous cell carcinoma (ESCC).

Chen H, Wang Z, Wang S, Zhang Z, Shi S.

Med Oncol. 2015 Jan;32(1):357. doi: 10.1007/s12032-014-0357-1. Epub 2014 Nov 27.

PMID:
25428380

Supplemental Content

Support Center